Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefapixant versus placebo in women with refractory or unexplained chronic cough and stress urinary incontinence
MOH_2019-11-26_008510Phase 3Recruiting
- Sponsor
- Merck & Co.
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic cough and chronic idiopathic cough (CIC) comparing Gefapixant with Placebo (2 arms). Started Nov 2019; status: recruiting.
02
Drugs
gefapixant
03
Conditions
chronic coughchronic idiopathic cough (CIC)
Beyond the preview
Go deeper on MOH_2019-11-26_008510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-11-26_008510.